Innova Captab Ltd

Innova Captab has shown consistent growth over the past three years, with net sales rising from 926.38 Cr in Mar'23 to 1,243.68 Cr in Mar'25, and profit after tax increasing from 67.95 Cr to 128.26 Cr. The company's total assets and liabilities also expanded significantly during this period.

As of 14-Nov, Innova Captab Ltd's stock price is 752.00, having increased by 3.02% recently. However, it has underperformed long-term with a -31.88% year-to-date return and faces challenges such as declining investor participation and overall negative sentiment.

As of 10-Nov, Innova Captab Ltd's stock price is Rs 738.40, down 3.82% and has fallen 10.6% over the last three days. Despite strong debt servicing capabilities, recent poor financial results and underperformance against benchmarks have led to a significant decline in its stock value.

Innova Captab's latest results show strong revenue growth with net sales up 19.54% year-on-year, but profitability has declined significantly, with net profit down 15.23% and margins contracting, indicating operational challenges that need to be addressed.

As of November 6, 2025, Innova Captab is considered undervalued with an attractive valuation grade, featuring a PE ratio of 35.54, an EV to EBITDA of 24.91, and a PEG ratio of 0.99, indicating better growth potential compared to peers despite recent underperformance against the Sensex.

As of November 4, 2025, Innova Captab is fairly valued with a PE ratio of 36.20, an EV to EBITDA ratio of 25.34, and a ROE of 13.37%, despite a year-to-date return of -25.63% compared to the Sensex's 6.81%.

As of November 4, 2025, Innova Captab is fairly valued with a PE ratio of 36.20 and an EV to EBITDA of 25.34, showing a year-to-date performance of -25.63%, indicating potential overvaluation compared to peers like Cipla and Sun Pharma.

As of November 3, 2025, Innova Captab is considered undervalued with an attractive valuation grade, a PE ratio of 35.82, and a PEG ratio of 1.00, despite a year-to-date decline of 26.41%, while outperforming the Sensex recently.

Innova Captab demonstrated consistent growth from March 2023 to March 2025, with net sales increasing from 926.38 Cr to 1,243.68 Cr and profit after tax rising from 67.95 Cr to 128.26 Cr, reflecting enhanced operational efficiency and profitability. Total assets also grew significantly, indicating a strong financial position.

As of October 30, 2025, Innova Captab is fairly valued with a PE Ratio of 36.65, an EV to EBITDA of 25.64, and a ROE of 13.37%, outperforming the Sensex with a 9.38% return, while its PEG Ratio of 1.02 suggests reasonable pricing relative to growth expectations.

As of 29 October 2025, the technical outlook for Innova Captab has shifted to bearish, supported by bearish indicators from the weekly MACD, daily moving averages, and a mildly bearish trend in Bollinger Bands.

As of 28 October 2025, the market trend is mildly bearish with mixed signals, as the weekly MACD is bearish, the RSI is bullish, daily moving averages are bearish, and Dow Theory and On-Balance Volume also indicate a cautious bearish outlook.

Innova Captab has shown significant growth over the past three years, with net sales increasing from 926.38 Cr in Mar'23 to 1,243.68 Cr in Mar'25, and profit after tax rising from 67.95 Cr to 128.26 Cr. Despite rising raw material costs, the company has maintained strong profitability and asset growth.